Business · 27/12/2013Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of Roxarsone Animal Drug Applications
Summary
The Food and Drug Administration (FDA) has withdrawn approval of five new animal drug applications for roxarsone oral dosage form products at the sponsor's request due to the products no longer being manufactured or marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →